研究文章
围神经的入侵应当被视为一个中度风险因素在手术治疗宫颈癌复发:倾向得分匹配研究
|
| 病人的特点 |
PSM之前 |
PSM后 |
| 句(+), |
句(-), |
|
句(+), |
句(-), |
|
|
| 平均年龄(岁) |
|
|
0.03 |
|
|
0.05 |
|
| 平均肿瘤大小(厘米) |
|
|
0.01 |
|
|
0.93 |
|
| 病理类型 |
鳞状上皮细胞癌 |
116例(71.6%) |
1462例(87.3%) |
0.02 |
116例(71.6%) |
118例(72.8%) |
0.89 |
| 腺癌 |
31 (19.1%) |
153例(9.1%) |
31 (19.1%) |
28 (17.3%) |
| Adenosquamous癌 |
15 (9.3%) |
59 (3.5%) |
15 (9.3%) |
16 (9.9%) |
|
| 肿瘤分化 |
好吧 |
8 (4.9%) |
235例(14.0%) |
0.01 |
8 (4.9%) |
6 (3.7%) |
0.93 |
| 温和的 |
63例(38.9%) |
724例(43.3%) |
63例(38.9%) |
63例(38.9%) |
| 可怜的 |
91例(56.2%) |
715例(42.7%) |
91例(56.2%) |
93例(57.4%) |
|
| 菲戈阶段 |
IA2 |
0 |
63例(3.8%) |
0.01 |
0 |
0 |
0.96 |
| IB1 |
41 (25.3%) |
752例(44.9%) |
41 (25.3%) |
38 (23.5%) |
| IB2 |
13 (8.0%) |
209例(12.5%) |
13 (8.0%) |
14 (8.6%) |
| IIA1 |
59 (36.4%) |
204例(12.2%) |
59 (36.4%) |
60 (37.0%) |
| IIA2 |
26 (16.1%) |
136例(8.1%) |
26 (16.0%) |
27 (16.7%) |
| IIB |
23 (14.2%) |
98例(5.9%) |
23 (14.2%) |
23 (14.2%) |
|
| 主要治疗 |
根治手术 |
111例(68.5%) |
1284例(76.7%) |
0.01 |
111例(68.5%) |
98例(60.5%) |
0.12 |
| NACT |
51 (31.5%) |
390例(23.3%) |
51 (31.5%) |
64例(39.5%) |
|
| NACT课程 |
|
2.3 |
2 |
0.36 |
2.3 |
2.2 |
0.78 |
|
| 应对NACT |
聚合酶链反应 |
0 |
41 (10.5%) |
0.01 |
0 |
6 (9.4%) |
0.01 |
| CR |
0 |
52 (13.3%) |
0 |
7 (10.9%) |
| 公关 |
39 (76.5%) |
245例(62.8%) |
39 (76.5%) |
42 (65.6%) |
| SD |
11 (21.6%) |
40 (10.3%) |
11 (21.6%) |
9 (14.1%) |
| PD |
1 (2.0%) |
12 (3.1%) |
1 (2.0%) |
0 |
|
| 外科手术方法 |
微创手术 |
12 (7.4%) |
136例(8.1%) |
0.46 |
12 (7.4%) |
20 (12.3%) |
0.14 |
| 剖腹手术 |
150例(92.6%) |
1538例(91.9%) |
150例(92.6%) |
142例(87.7%) |
|
|
|
句:围神经的入侵;菲戈:国际妇产科联合会;NACT:新辅助化疗;pCR:病理完全缓解;克雷格:完全缓解;公关:部分缓解;SD:稳定的疾病;帕金森病:疾病进展。
|
